BMPR2 mutations and survival in pulmonary arterial hypertension: An individual participant data meta-analysis
Pulmonary arterial hypertension (PAH) is a rare disorder characterised by progressive remodelling of the small pulmonary arteries, resulting in increased pulmonary vascular resistance and ultimately right ventricular failure and death.[1,2] The diagnosis of PAH requires a mean pulmonary artery pressure of 25 mmHg or more with a pulmonary artery wedge pressure of 15 mmHg or less at right heart catheterisation in the absence of chronic thromboembolic, left heart or respiratory disease.
T Mnguni, Senior Registrar in Pulmonology, Groote Schuur Hospital and University of Cape Town, South Africa
Full Text:PDF (82KB)
Cite this article
Date published: 2016-12-19
Full text views: 123
- There are currently no refbacks.
African Journal of Thoracic and Critical Care Medicine| Online ISSN: 2617-0205 | © 2014 Health & Medical Publishing Group
Our Journals: South African Medical Journal | African Journal of Health Professions Education | South African Journal of Bioethics and Law | South African Journal of Child Health | Southern African Journal of Critical Care | South African Respiratory Journal | South African Journal of Obstetrics and Gynaecology |